Journal of Postgraduate Medicine, Education and Research

Register      Login

VOLUME 51 , ISSUE 4 ( October-December, 2017 ) > List of Articles

CASE REPORT

A Fatal Case of Pyrexia of Unknown Origin: Hemophagocytic Lymphohistiocytosis?

Palak Bhuta, Aakash Patel, Luv Yadav, Utsav Patel, Virendra Kosamia, Arti Muley

Citation Information : Bhuta P, Patel A, Yadav L, Patel U, Kosamia V, Muley A. A Fatal Case of Pyrexia of Unknown Origin: Hemophagocytic Lymphohistiocytosis?. J Postgrad Med Edu Res 2017; 51 (4):188-191.

DOI: 10.5005/jp-journals-10028-1261

Published Online: 01-06-2017

Copyright Statement:  Copyright © 2017; The Author(s).


Abstract

Aim

To highlight the need of high suspicion of hemophagocytic lymphohistiocytosis (HLH) in pyrexia of unknown origin (PUO) and also the need of specific guidelines for the management of the disease.

Background

The HLH is a rare disease of overactive histiocytes and lymphocytes. Although seen in all age groups, it is less common in adults as compared with infants. It usually presents with fever, hepatosplenomegaly, pancytopenia, lymphadenopathy, and rash. Cutaneous involvement is seen in as many as 65% of patients.

Case Report

A 25-year-old male presented with high-grade fever and cough since 4 weeks. Examination at presentation revealed only hepatosplenomegaly. During the course of the disease, he developed pancytopenia, but there was no lymphadenopathy or neurological or cutaneous manifestations. The patient was thoroughly investigated, but it remained inconclusive. He did not respond to any antibiotics, antimalarials, or antituberculars. There was an initial response to steroids, but it did not sustain. Bone marrow remained normal throughout the course of illness. Based on other features, we made a diagnosis of HLH, but the patient's condition worsened rapidly and proved to be fatal despite all treatment.

Conclusion and clinical significance

The HLH must be suspected in a case of PUO especially in presence of pancytopenia and hepatosplenomegaly. It is important to look for other features like hyperferritinemia and hypertriglyceridemia to reach an early diagnosis as bone marrow features may present very late during the course of illness. Early diagnosis is all the more important in view of rapidly progressive fatal course of the disease.

How to cite this article

Bhuta P, Patel A, Yadav L, Patel U, Kosamia V, Muley A. A Fatal Case of Pyrexia of Unknown Origin: Hemophagocytic Lymphohistiocytosis? J Postgrad Med Edu Res 2017;51(4):188-191.


PDF Share
  1. Malignancy-associated hemophagocytic lymphohistiocytosis in adults: a retrospective population-based analysis from a single center. Leuk Lymphoma 2011 Apr;52(4):613-619.
  2. Hemophagocytic lymphohistiocytosis presenting with nonimmune hydrops fetalis. J Perinatol 2004 Jul;24(7):458-460.
  3. Hemophagocytic syndromes–an update. Blood Rev 2014 Jul;28(4):135-142.
  4. Perforin gene mutations in adult-onset hemophagocytic lymphohistiocytosis. Haematologica 2007 Mar;92:978-981.
  5. Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH. Blood 2011 Nov;118(22):5794-5798.
  6. Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia 1996 Feb;10(2):197-203.
  7. Adverse outcomes in primary hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol 2002 Oct;24(7):550-554.
  8. Hemophagocytic syndromes. Blood Rev 2007 Sep;21(5):245-253.
  9. Pathogenesis of hemophagocytic syndrome (HPS). Autoimmun Rev 2004 Feb;3(2):69-75.
  10. Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematology Am Soc Hematol Educ Program 2009 Dec:127-131.
  11. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. Blood 2011 Oct;118(17):4577-4584.
  12. Serum ferritin is a cost-effective laboratory marker for hemophagocytic lymphohistiocytosis in the developing world. J Pediatr Hematol Oncol 2012 Apr;34(3):e89-e92.
  13. Determination of an appropriate cut-off value for ferritin in the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2014 Nov;61(11):2101-2103.
  14. Longitudinal follow-up of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Haematologica 2004 Feb;89(2):183-188.
  15. Unrelated bone marrow transplantation induced longterm remission in a patient with life-threatening Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Clin Exp Hematop 2011;51(1):57-61.
  16. Secondary hemophagocytic syndrome in adults: a case series of 18 patients in a single institution and a review of literature. Hematol Oncol 2011 Jun;29(2):100-106.
  17. Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan. Pediatr Blood Cancer 2010 Feb;54(2):299-306.
  18. HLH-2004:diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007 Feb;48(2):124-131.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.